Illumina (ILMN) Income from Non-Controlling Interests (2015 - 2019)
Illumina (ILMN) reported Income from Non-Controlling Interests of -$3.0 million for Q2 2019, up 66.67% on a YoY basis from -$1.8 million in Q2 2018, and up 66.67% quarter-over-quarter from -$9.0 million in Q1 2019.
Illumina (ILMN) Income from Non-Controlling Interests (2015 - 2019) Analysis & Trends
Illumina has reported Income from Non-Controlling Interests for 5 years, with the latest figure at -$3.0 million in Q2 2019.
- For the quarter ending Q2 2019, Income from Non-Controlling Interests rose 66.67% year-over-year to -$3.0 million; the trailing twelve-month figure through Mar 2020 stood at -$3.0 million (up 92.86% YoY), and the FY2019 full-year result was -$12.0 million, up 72.73% from the prior year.
- Income from Non-Controlling Interests for Q2 2019 stood at -$3.0 million, up from -$9.0 million in the prior quarter.
- The five-year high for Income from Non-Controlling Interests was -$1.6 million in Q1 2016, with the low at -$19.0 million in Q2 2017.
- Historically, Income from Non-Controlling Interests has averaged -$8.5 million across 5 years, with a median of -$9.0 million in 2018.
- Annual changes were most pronounced in 2017 — Income from Non-Controlling Interests tumbled 850.0% — and 2019, when it surged 66.67%.
- Illumina's Income from Non-Controlling Interests stood at -$2.6 million in 2015, then tumbled by 369.48% to -$12.0 million in 2016, then climbed by 8.33% to -$11.0 million in 2017, then dropped by 18.18% to -$13.0 million in 2018, then soared by 76.92% to -$3.0 million in 2019.
- The last three Income from Non-Controlling Interests figures came in at -$3.0 million (Q2 2019), -$9.0 million (Q1 2019), and -$13.0 million (Q4 2018), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 5.00 Mn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | - |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | - |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | - |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | - |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 1.00 Mn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | - |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | - |
| 10 | Quest Diagnostics | 22.51 Bn | 22.42 Bn | 942.00 Mn | 12.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | -3.00 Mn |
| Mar 31, 2019 | -9.00 Mn |
| Dec 30, 2018 | -13.00 Mn |
| Sep 30, 2018 | -11.00 Mn |
| Jul 1, 2018 | -9.00 Mn |
| Apr 1, 2018 | -11.00 Mn |
| Dec 31, 2017 | -11.00 Mn |
| Oct 1, 2017 | -11.00 Mn |
| Jul 2, 2017 | -8.00 Mn |
| Apr 2, 2017 | -19.00 Mn |
| Oct 2, 2016 | -12.00 Mn |
| Jul 3, 2016 | -4.00 Mn |
| Apr 3, 2016 | -2.00 Mn |
| Jan 3, 2016 | -1.61 Mn |
| Sep 27, 2015 | -2.56 Mn |